Document is current

Article History

Received: 20 December 2024

Accepted: 13 March 2025

First Online: 8 May 2025

Declarations

:

: Gemma Soler has no conflicts of interest. Cristina Grávalos has no conflicts of interest. Fernando Rivera has received advisory/consultancy fees from Amgen, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Celgene, Lilly, Merck KGaA, Merck Sharp & Dohme, Organon, Hoffmann-La Roche, Sanofi, and Servier; speaker engagements from Amgen, Bayer, Bristol Myers Squibb, Celgene, Lilly, Merck KGaA, Merck Sharp & Dohme, Hoffmann-La Roche, Sanofi, and Servier; research funding from Amgen, Bayer, Celgene, Lilly, Merck KGaA, Merck Sharp & Dohme, Hoffmann-La Roche, Sanofi, and Servier; and grants and other fundings from Amgen, Bristol Myers Squibb, and Merck Sharp & Dohme. María José Safont has received advisory/consultancy fees from Amgen, Bayer, Bristol Myers Squibb, Merck KGaA, Merck Sharp & Dohme, Pierre Fabre, Pfizer, and Servier; and speaker engagements from Amgen, Bristol Myers Squibb, Lilly, Merck KGaA, Merck Sharp & Dohme, Servier, and Takeda. Anna C. Virgili has received advisory/consultancy fees from Merck KGaA, and Pierre Fabre; and travel grants from Amgen, Merck KGaA, and Merck Sharp & Dohme. Manuel Valladares-Ayerbes has received advisory/consultancy fees from Amgen, Sanofi, and Servier; speaker engagements from Bristol Myers Squibb, Merck KGaA, and Merck Sharp & Dohme; grants and other fundings from Amgen, Merck KGaA, Hoffmann-La Roche, and Servier. Reyes Ferreiro-Monteagudo has received advisory/consultancy fees from Amgen; speaker engagements from Amgen, Merck KGaA, Merck Sharp & Dohme, Servier and Takeda. María Jose Ortiz-Morales has no conflicts of interest. Eduardo Polo-Marqués has received advisory/consultancy fees from Amgen, Leo Pharma, Merck KGaA, Novartis, Pierre-Fabre, and Servier. Irina Kornusova-Bersheva is an employee of Laboratorios Servier in Spain. Elsa Soustre is an employee of Laboratorios Servier in Spain. Weiyu Yao is an employee of Servier Pharmaceuticals in Boston, MA, USA. Elena Élez has received advisory/consultancy fees from Agenus, Amgen, Bayer, Bristol Myers Squibb, Boehringer Ingelheim, CureTeq AG, GlaxoSmithKline, Hoffmann-La Roche, Janssen Cilag, Johnson & Johnson, Lilly, Medscape, Merck KGaA, Merck Sharp & Dohme, Novartis, Organon, Pfizer, Pierre Fabre, Repare Therapeutics Inc., RIN Institute Inc., Rottapharm Biotech, Sanofi, Seagen International GmbH, Servier, and Takeda; speaker engagements from Agenus, Amgen, Bayer, Bristol Myers Squibb, Boehringer Ingelheim, CureTeq AG, GlaxoSmithKline, Hoffmann-La Roche,, Janssen Cilag, Johnson & Johnson, Lilly, Medscape, Merck KGaA, Merck Sharp & Dohme, Novartis, Organon, Pfizer, Pierre Fabre, Repare Therapeutics Inc., RIN Institute Inc., Rottapharm Biotech, Sanofi, Seagen International GmbH, Servier, and Takeda; and grants and institutional grants and other fundings from Abbvie, Agenus, Amgen, Array Biopharma, AstraZeneca, Bayer, BeiGene, Bioncotech, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Daiichi Sankyo, Debiopharm International SA, Enterome BioScience, Exelixis, Genentech, Gercor, GlaxoSmithKline, HalioDX SAS, Hoffmann-La Roche, Hutchinson Medipharma, Iovance Biotherapeutics, Janssen Cilag, MedImmune, Menarini, Merck KGaA, Merck Sharp & Dohme, Merus NV, Mirati, Nouscom, Novartis, Pfizer, NuCana plc., PharmaMar, Pledpharma AB, Redx Pharma PLC, Sanofi, Scandion Oncology, Seattle Genetics Inc., Servier, Sotio, Taiho Pharma, and Wntresearch AB.

: The study has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.

: This article does not contain any studies directly involving human participants, as it is a review of data already collected in a hernia database.

: Not applicable.